213 related articles for article (PubMed ID: 1715361)
21. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
[TBL] [Abstract][Full Text] [Related]
22. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.
Johnson RP; Trocha A; Buchanan TM; Walker BD
J Virol; 1993 Jan; 67(1):438-45. PubMed ID: 7677956
[TBL] [Abstract][Full Text] [Related]
23. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
[TBL] [Abstract][Full Text] [Related]
24. An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope.
Nixon DF; Huet S; Rothbard J; Kieny MP; Delchambre M; Thiriart C; Rizza CR; Gotch FM; McMichael AJ
AIDS; 1990 Sep; 4(9):841-5. PubMed ID: 1701304
[TBL] [Abstract][Full Text] [Related]
25. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
Cao H; Kanki P; Sankalé JL; Dieng-Sarr A; Mazzara GP; Kalams SA; Korber B; Mboup S; Walker BD
J Virol; 1997 Nov; 71(11):8615-23. PubMed ID: 9343219
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 variation diminishes CD4 T lymphocyte recognition.
Harcourt GC; Garrard S; Davenport MP; Edwards A; Phillips RE
J Exp Med; 1998 Nov; 188(10):1785-93. PubMed ID: 9815256
[TBL] [Abstract][Full Text] [Related]
28. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
Yu XG; Shang H; Addo MM; Eldridge RL; Phillips MN; Feeney ME; Strick D; Brander C; Goulder PJ; Rosenberg ES; Walker BD; Altfeld M;
AIDS; 2002 Feb; 16(3):321-8. PubMed ID: 11834942
[TBL] [Abstract][Full Text] [Related]
29. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
31. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
[TBL] [Abstract][Full Text] [Related]
32. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
Zhang W; Lonning SM; McGuire TC
J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
[TBL] [Abstract][Full Text] [Related]
33. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
[TBL] [Abstract][Full Text] [Related]
35. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
36. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
[TBL] [Abstract][Full Text] [Related]
37. CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition.
Ferrari G; Neal W; Jones A; Olender N; Ottinger J; Ha R; McElrath MJ; Goepfert P; Weinhold KJ
Immunol Lett; 2001 Nov; 79(1-2):37-45. PubMed ID: 11595288
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
[TBL] [Abstract][Full Text] [Related]
39. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
40. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.
Sipsas NV; Kalams SA; Trocha A; He S; Blattner WA; Walker BD; Johnson RP
J Clin Invest; 1997 Feb; 99(4):752-62. PubMed ID: 9045880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
